Advanced Biomed (ADVB) Return on Capital Employed (2025 - 2026)

Advanced Biomed (ADVB) posted Return on Capital Employed of 49.66% for Q1 2026, down 7.63% sequentially from 53.76% in Q4 2025, and up 17460.0% YoY from N/an in Q1 2025.

Advanced Biomed (ADVB) Return on Capital Employed (2025 - 2026) Analysis & Trends

Advanced Biomed (ADVB) has 2 years of Return on Capital Employed data on file, last reported at 49.66% in Q1 2026.

  • Quarterly Return on Capital Employed rose 17460.0% year-over-year to 49.66% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 49.66% (up 17460.0% YoY) and the FY2025 annual result came in at 297.97%, changed N/A from the prior year.
  • Return on Capital Employed retreated to 49.66% in Q1 2026 per ADVB's latest filing, from 53.76% in the prior quarter.
  • The five-year high for Return on Capital Employed was 53.76% in Q4 2025, with the low at 389.74% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn 4.82%
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn 8.12%
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn 6.26%
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn 67.98%
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn -3.63%
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn 14.57%
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn 10.24%
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn 16.90%
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn 45.73%
10 Advanced Biomed 6.22 Mn 6.22 Mn - 49.66%

Historic Data

Download Data
DateValue
Mar 31, 2026 49.66%
Dec 31, 2025 53.76%
Sep 30, 2025 -52.78%
Jun 30, 2025 -389.74%
Mar 31, 2025 -124.95%